Patricia Lowden

Reduction of product-related species during the fermentation and purification of a recombinant IL-1 receptor antagonist at the laboratory and pilot scale.

Jin Xu, Gregory Zarbis-Papastoitsis, S. Mulagapati, 2013, Biotechnology journal.

Preclinical Development of EBI-005: a Potent Interleukin-1 (IL-1) Receptor-1 (R1) Blocker for Topical Ocular Administration was Safe in GLP Toxicology Studies and Active in a Mouse Model of Dry Eye Disease (DED)

E. Furfine, A. Masci, J. Milling, 2013 .

Crystal structure of an HSA/FcRn complex reveals recycling by competitive mimicry of HSA ligands at a pH-dependent hydrophobic interface.

Michael M. Schmidt, Bracken M. King, K. Wittrup, 2013, Structure.

Specificity and Structure of a High Affinity Activin Receptor-like Kinase 1 (ALK1) Signaling Complex

A. Grinberg, Ravindra Kumar, J. Seehra, 2012, The Journal of Biological Chemistry.

Reduction of product-related species during the fermentation and purification of a recombinant IL-1 receptor antagonist at the laboratory and pilot scale.

Jin Xu, Gregory Zarbis-Papastoitsis, S. Mulagapati, 2013, Biotechnology journal.

Specificity and Structure of a High Affinity Activin Receptor-like Kinase 1 (ALK1) Signaling Complex

A. Grinberg, Ravindra Kumar, J. Seehra, 2012, The Journal of Biological Chemistry.